It is now known that AD is associated with global reductions in cerebral glucose metabolism, and the crucial role of the insulin/IGF-I pathway in neuronal cell function has led to the hypothesis of AD as a “diabetes type 3” [129]. The gene discussed is IGF1; the disease is Alzheimer disease.